Merck Opens Application Phase for Next Accelerator

MerckMerck, a leading science and technology company, today announced that it has opened the next round of applications for startup companies to participate in the global Merck Accelerator program. Startups can choose to participate in one of the two programs, either at the company's Innovation Center at global headquarters in Darmstadt or at its China Innovation Hub in Shanghai.

"We generate new business by driving innovation beyond what we are currently doing," said Isabel De Paoli, Chief Strategy Officer at Merck. "Collaborating with startups around the globe via the Merck Accelerator offers the exciting opportunity to create a win-win situation for both the startups and Merck. They gain access to a strong partner with a lot of experience in partnerships that helps them to accelerate their industry-ready business, whereas we obtain fresh stimulus to drive innovation beyond our current activities. Joining forces can create an impact in tackling the challenges of humanity."

The Merck Accelerator with programs in Germany and in China connects startups to innovation projects of Merck and its three business sectors for co-development and sustainable business partnerships. During a three-month period, startups receive financial support of up to € 50,000 and benefit from in-depth coaching from a global network of over 50,000 experts, as well as mentoring from Merck senior management, coaching sessions and visibility by attending inspirational and renowned events in the startup ecosystem.

In Darmstadt, the chosen startups will have access to the modern workspace at the futuristic Merck Innovation Center with prototyping facilities in the Makerspace. In China, startups will have access to the local Merck network and mixed sites such as Guangzhou, Beijing and Shanghai with different business focus and ecosystems.

Besides the core areas of Merck research in Healthcare, Life Science and Performance Materials, the main focus of the Merck Accelerator is to partner with startups in the company's innovation fields:

  • Biosensing & Interfaces: technologies to interface between the biological and digital world
  • Liquid Biopsy Technologies: solutions to overcome challenges in the liquid biopsy workflow
  • Clean Meat: enabling technology required to produce clean meat (specifically for the headquarters program at the Innovation Center)
  • AI-enabled health solutions that include AI solutions for diagnosis rate improvement and precision medicine; AI-enabled drug R&D; Digital therapeutics (specifically for the program in China)

"We have a lot of experience in partnering with startups. To make collaboration happen, we ensure startups the right connections within Merck," said Michael Gamber, Head of Merck Innovation Center. "The last intake of the Merck Accelerator at the Innovation Center was incredibly successful and 90% of the startups are either collaborating or in negotiations to partner with us."

For example, iXensor, a startup alumni that recently completed from the Merck Accelerator program at the Innovation Center in April, is one of the startups that reached a collaboration with Merck to gain initial access to the African market. The Taiwanese startup conducted a first successful pilot test at Merck CURAFATM points of care in Kenya and provided its latest technology devices to support an initiative that seeks to improve primary healthcare access for the local underserved population in emerging economies.

So far, 57 startups have already participated in the Merck Accelerator program since the first intake in 2015. Merck is currently looking for up to 12 startups to participate in the program in Darmstadt and up to six startups for its China Innovation Hub.

The Accelerator programs will simultaneously take place from mid-January to April 2020 at the Merck Innovation Center in Darmstadt and at the China Innovation Hub. Right after each program, selected startups will also have the opportunity to extend their stay either in China or in Darmstadt. Applications for both programs are open from now until August 25, 2019.

For more information, please visit:
https://www.merckgroup.com/en/research/innovation-center/accelerator.html

About the Merck Innovation Center

Complementing research and development in the company’s business sectors, the Merck Innovation Center supports the scaling of new businesses beyond the company's current scope. With its initiatives, creative working environment and culture of openness and exchange, the Innovation Center connects employees, startups and companies to create groundbreaking innovations.

About the China Innovation Hub

As part of the Merck global innovation network, the China Innovation Hub scouts, incubates and invests in innovative opportunities in Merck's current businesses and in fields between and beyond these. The China Innovation Hub is committed to partnering with start-ups, academic institutions, industry players and local governments. By combining unique technology and expertise from the Merck Group and collaborators, the aim is to develop novel technologies and bring new solutions to the market for China and the rest of the world. The China Innovation Hub also provides support of ideation, incubation and training to local talent, partners and Merck employees to build win-win collaborations.

Most Popular Now

Is Your Marketing Effective for an NHS C…

How can you make sure you get the right message across to an NHS chief information officer, or chief nursing information officer? Replay this webinar with Professor Natasha Phillips, former...

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

Using AI to Treat Infections more Accura…

New research from the Centres for Antimicrobial Optimisation Network (CAMO-Net) at the University of Liverpool has shown that using artificial intelligence (AI) can improve how we treat urinary tract infections...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...